147 related articles for article (PubMed ID: 21317475)
1. Seroprevalence of hepatitis A virus antibody in Bijapur, Karnataka.
Rath CP; Akki A; Patil SV; Kalyanshettar SS
Indian Pediatr; 2011 Jan; 48(1):71-3. PubMed ID: 21317475
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey.
Halicioglu O; Akman SA; Tatar B; Atesli R; Kose S
Travel Med Infect Dis; 2012 Jan; 10(1):43-7. PubMed ID: 22264583
[TBL] [Abstract][Full Text] [Related]
3. Impact of travel on the seroprevalence of hepatitis A in children.
Faillon S; Martinot A; Hau I; Puget A; Moulin F; Noel G; Guen CG; Lorrot M; Callamand P; Hue V; Meritet JF; Gendrel D; Dubos F
J Clin Virol; 2013 Jan; 56(1):46-51. PubMed ID: 23127561
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
6. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
Joshi N; Yr NK; Kumar A
Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey.
Kaya D; Guler E; Ekerbicer HC; Dilber C; Karabiber H; Guler S; Davutoglu M; Ciragil P
J Viral Hepat; 2007 Dec; 14(12):830-4. PubMed ID: 18070285
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy.
Sofian M; Aghakhani A; Farazi AA; Banifazl M; Etemadi G; Azad-Armaki S; Ziazarifi A; Abhari Z; Eslamifar A; Khadem-Sadegh A; Izadi N; Ramezani A
Travel Med Infect Dis; 2010 May; 8(3):176-9. PubMed ID: 20541138
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis a in Lebanon: a changing epidemiological pattern.
Sacy RG; Haddad M; Baasiri G; Khoriati A; Gerbaka BJ; Abu-Elyazeed R
Am J Trop Med Hyg; 2005 Aug; 73(2):453-6. PubMed ID: 16103621
[TBL] [Abstract][Full Text] [Related]
11. [A study on seroprevalence of anti-HAV IgG in adults of 4 cities in China].
Cheng YY; Nie JJ; Li J; Hou JL; Zhang XX; Ning Q; Gao XY; Ding HF; Liu XE; Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):896-9. PubMed ID: 20038329
[TBL] [Abstract][Full Text] [Related]
12. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
13. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
14. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
[TBL] [Abstract][Full Text] [Related]
15. Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study.
Sagnelli E; Stroffolini T; Almasio P; Mele A; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
J Viral Hepat; 2006 Jan; 13(1):67-71. PubMed ID: 16364085
[TBL] [Abstract][Full Text] [Related]
16. Immunity to hepatitis A and hepatitis B in Indian and Chinese immigrants seen in a travel clinic in Massachusetts, United States.
Ooi WW; Gallagher A; Chen LH
J Travel Med; 2006; 13(4):212-8. PubMed ID: 16884403
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study.
C MA; J M RT; A CR; M BN; M DG; S L MR
J Med Virol; 2013 Oct; 85(10):1692-7. PubMed ID: 23861034
[TBL] [Abstract][Full Text] [Related]
18. The relation between anti-hepatitis A virus antibodies and residence water access in Rio de Janeiro, Brazil.
Luiz RR; Almeida RM; Almeida RT; de Almeida LM
Int J Hyg Environ Health; 2003 Oct; 206(6):575-82. PubMed ID: 14626904
[TBL] [Abstract][Full Text] [Related]
19. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of hepatitis A virus infection among schoolchildren in Taiwan.
Tsai CF; Lin DB; Chen SC; Chang YH; Chen CY; Lin JB
J Med Virol; 2011 Feb; 83(2):196-200. PubMed ID: 21181912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
